Systematic review / meta-analysis / 2012
Higher dietary lutein and zeaxanthin intake was linked to a lower risk of late and neovascular AMD, but not early AMD.
A systematic review and meta-analysis of six longitudinal cohort studies examined the relationship between dietary lutein and zeaxanthin intake and age-related macular degeneration (AMD) risk. Comparing the highest with the lowest intake categories, the pooled relative risk was 0.96 (95% CI 0.78, 1.17) for early AMD. Intake was significantly linked to a reduced risk of late AMD (RR 0.74; 95% CI 0.57, 0.97) and neovascular AMD (RR 0.68; 95% CI 0.51, 0.92).
Shows an association, not proof of cause and effect.
- Study type
- Systematic review and meta-analysis of cohort studies
- Who was studied
- Participants in six longitudinal cohort studies identified up to April 2010
- What was measured
- Risk of early AMD, late AMD, and neovascular AMD
THE PAPER
Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis.
Ma L, Dou HL, Wu YQ, Huang YM, Huang YB, Xu XR, Zou ZY, Lin XM. Br J Nutr, 2012.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.